Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort

To reduce treatment of indolent prostate cancer (PCa), biomarkers are needed to improve identification of patients with a low-risk of having aggressive disease. Over-treatment of these patients occurs because of uncertainty in the aggressiveness of the entire tumor based on the biopsies, which do no...

Ausführliche Beschreibung